| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
24,974 |
280,973 |
411,250 |
790,845 |
| Total Sell Value |
$9,676,524 |
$108,309,729 |
$148,037,804 |
$243,516,438 |
| Total People Sold |
8 |
12 |
13 |
13 |
| Total Sell Transactions |
20 |
41 |
56 |
83 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guthart Gary S |
President & CEO |
• • – |
2019-12-05 |
4 |
AS |
$582.12 |
$13,026,084 |
D/D |
(22,377) |
373,728 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2019-12-05 |
4 |
OE |
$113.73 |
$3,625,144 |
D/D |
31,875 |
396,105 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2019-12-02 |
4 |
AS |
$586.66 |
$7,262,464 |
D/D |
(12,368) |
4,143 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2019-12-02 |
4 |
OE |
$178.39 |
$4,641,207 |
D/D |
11,140 |
5,675 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,000 |
347,691 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
278,952 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2019-11-19 |
4 |
AS |
$580.00 |
$580,000 |
D/D |
(1,000) |
4,298 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2019-11-19 |
4 |
OE |
$193.08 |
$193,080 |
D/D |
1,000 |
5,298 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,049 |
287,691 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
84 |
290,656 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-08 |
4 |
S |
$554.49 |
$113,670 |
I/I |
(205) |
260,656 |
|
- |
|
| Rosa David J. |
EVP and Chief Business Officer |
• – – |
2019-11-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,884 |
10,360 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
290,861 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-11-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
338,952 |
|
- |
|
| Leonard Keith R |
Director |
– • – |
2019-11-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
513 |
332 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-10-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
83 |
3,018 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-10-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
234 |
12,401 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-10-28 |
4 |
AS |
$548.43 |
$4,113,258 |
D/D |
(7,500) |
12,635 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2019-10-28 |
4 |
OE |
$113.73 |
$852,975 |
D/D |
7,500 |
20,135 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-10-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
743 |
260,861 |
|
- |
|
| Smith Lonnie M |
Director |
– • – |
2019-10-23 |
4 |
GA |
$0.00 |
$0 |
D/D |
743 |
368,952 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-10-22 |
4 |
AS |
$552.39 |
$1,660,609 |
D/D |
(3,000) |
3,101 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2019-10-22 |
4 |
OE |
$189.74 |
$637,038 |
D/D |
3,000 |
4,601 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2019-10-22 |
4 |
AS |
$553.29 |
$1,131,916 |
D/D |
(2,042) |
3,176 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2019-10-22 |
4 |
OE |
$170.76 |
$256,135 |
D/D |
1,500 |
5,218 |
|
- |
|
1324 Records found
|
|
Page 23 of 53 |
|
|
5.92 (1.56%) 
